Drugs / Oralgam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00110708 | Apr 2005 → Jun 2006 | autism, digestive system disorder | PediaMed Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oralgam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00110708 ↗ |
| Known as | human immunoglobulin | “Oralgam (human immunoglobulin)” NCT00110708 ↗ |
| Modality | Protein / enzyme biologic | “oral human immunoglobulin” NCT00110708 ↗ |
| Route | Oral | “human immunoglobulin given by mouth twice a day” NCT00110708 ↗ |